118 results
Page 2 of 6
8-K
EX-99.3
m5mle5f408197z3va4i
23 May 23
Regulation FD Disclosure
7:06am
8-K
EX-99.1
ww3k6skgrvlgnmbrp0
15 May 23
OTL-200 Biologics License Application (BLA) submission completion anticipated in mid-2023
7:05am
8-K
EX-99.1
86kjpifpo9keo i5sqq
12 Dec 22
Regulation FD Disclosure
4:22pm
8-K
EX-99.2
8qora2x03qyfoxyrt nb
12 Dec 22
Regulation FD Disclosure
4:22pm
8-K
EX-99.1
3xq32z7zs 3u
14 Nov 22
Orchard Therapeutics Reports Third Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:10am
8-K
EX-5.1
et222
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-1.1
ajqd6yofux7gicgmx 8c
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
424B5
84dpihnk6ilnnh8o7s
6 Oct 22
Prospectus supplement for primary offering
4:12pm
S-8
EX-5.1
3u234 iza
4 Aug 22
Registration of securities for employees
7:40am
8-K
EX-99.1
r7pp5qs sohkti
4 Aug 22
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
7:05am
8-K
EX-99.1
dz0k 1hc6goaedim
12 May 22
Orchard Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Commercial Progress
7:05am
S-3
EX-5.1
s7551x3f
30 Mar 22
Shelf registration
8:26am
S-3
spaf8ahk
30 Mar 22
Shelf registration
8:26am
POSASR
EX-5.1
9mg3dmzm
30 Mar 22
Automatic shelf registration (post-effective amendment)
7:57am